- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Endocrinology
Volume 2013 (2013), Article ID 571606, 7 pages
Twenty Years of Experience with the Preoperative Diagnosis of Medullary Cancer in a Moderately Iodine-Deficient Region
1Thyroid Outpatient Department, Bugat Hospital, 6 Fenyves Street, Matrafured, Gyongyos 3232, Hungary
2Department of Pathology, Bugat Hospital, Dozsa Gyorgy Street, Gyongyos 3200, Hungary
3Department of Nuclear Medicine, Honved Hospital, 44 Robert Karoly Avenue, Budapest 1134, Hungary
4Department of Surgery, Telki Hospital, Telki 2089, Hungary
Received 9 December 2012; Revised 20 January 2013; Accepted 30 January 2013
Academic Editor: A. L. Barkan
Copyright © 2013 Tamas Solymosi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- T. A. McCook, C. E. Putman, J. K. Dale, and S. A. Wells, “Medullary carcinoma of the thyroid: radiographic features of a unique tumor,” The American Journal of Roentgenology, vol. 139, no. 1, pp. 149–155, 1982.
- G. Costante, D. Meringolo, C. Durante et al., “Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 2, pp. 450–455, 2007.
- R. Cohen, J. M. Campos, C. Salaun et al., “Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 2, pp. 919–922, 2000.
- K. E. Melvin and A. H. Tashjian, “The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid,” Proceedings of the National Academy of Sciences of the United States of America, vol. 59, no. 4, pp. 1216–1222, 1968.
- M. D. Raj, S. Grodski, S. A. Martin, M. Yeung, and J. W. Serpell, “The role of fine-needle aspiration cytology in the surgical management of thyroid cancer,” Australian and New Zealand Journal of Surgery, vol. 80, no. 11, pp. 827–830, 2010.
- J. R. Hahm, M. S. Lee, Y. K. Min et al., “Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases,” Thyroid, vol. 11, no. 1, pp. 73–80, 2001.
- C. E. Jackson, G. B. Talpos, A. Kambouris, J. B. Yott, A. H. Tashjian Jr., and M. A. Block, “The clinical course after definitive operation for medullary thyroid carcinoma,” Surgery, vol. 94, no. 6, pp. 995–1001, 1983.
- G. Papi, S. M. Corsello, K. Cioni et al., “Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: a multicenter study,” Journal of Endocrinological Investigation, vol. 29, no. 5, pp. 427–437, 2006.
- B. Busnardo, M. E. Girelli, N. Simioni, D. Nacamulli, and E. Busetto, “Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma,” Cancer, vol. 53, no. 2, pp. 278–285, 1984.
- Y. N. You, V. Lakhani, S. A. Wells Jr., and J. F. Moley, “Medullary thyroid cancer,” Surgical Oncology Clinics of North America, vol. 15, no. 3, pp. 639–660, 2006.
- H. Gharib, E. Papini, R. Paschke et al., “American association of clinical endocrinologists, associazione medici endocrinologi, and european thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations,” Endocrine Practice, vol. 16, no. 3, pp. 468–475, 2010.
- Vierhapper, B. Niederle, C. Bieglmayer, K. Kaserer, and S. Baumgartner-Parzer, “Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders,” Thyroid, vol. 15, no. 11, pp. 1267–1272, 2005.
- B. L. Herrmann, K. W. Schmid, R. Goerges, M. Kemen, and K. Mann, “Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease,” European Journal of Endocrinology, vol. 162, no. 6, pp. 1141–1145, 2010.
- T. Rink, P. Truong, H. Schroth, J. Diener, M. Zimny, and F. Grünwald, “Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease,” Thyroid, vol. 19, no. 4, pp. 327–332, 2009.
- M. Hasselgren, L. Hegedüs, C. Godballe, and S. J. Bonnema, “Benefit of measuring basal serum calcitonin to detect medullary thyroid carcinoma in a Danish population with a high prevalence of thyroid nodules,” Head and Neck, vol. 32, no. 5, pp. 612–618, 2010.
- G. Chambon, C. Alovisetti, C. Idoux-Louche et al., “The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, pp. 75–81, 2011.
- M. Rieu, M. C. Lame, A. Richard et al., “Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules,” Clinical Endocrinology, vol. 42, no. 5, pp. 453–460, 1995.
- F. Pacini, M. Fontanelli, L. Fugazzola et al., “Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 78, no. 4, pp. 826–829, 1994.
- A. G. Özgen, F. Hamulu, F. Bayraktar et al., “Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter,” Thyroid, vol. 9, no. 6, pp. 579–582, 1999.
- T. Lee, H. Yang, S. Lin et al., “The accuracy of fine-needle aspiration biopsy and frozen section in patients with thyroid cancer,” Thyroid, vol. 12, no. 7, pp. 619–626, 2002.
- M. C. Vantyghem, P. Pigny, E. Leteurtre et al., “Thyroid carcinomas involving follicular and parafollicular C cells: seventeen cases with characterization of RET oncogenic activation,” Thyroid, vol. 14, no. 10, pp. 842–847, 2004.
- T. Solymosi, G. L. Tóth, I. Gál, C. Sajgó, and I. Szabolcs, “Influence of iodine intake on the diagnostic power of fine-needle aspiration cytology of the thyroid gland,” Thyroid, vol. 12, no. 8, pp. 719–723, 2002.
- P. Trimboli, S. Ulisse, F. M. Graziano et al., “Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years,” Thyroid, vol. 16, no. 11, pp. 1151–1155, 2006.
- Z. W. Baloch, M. J. Sack, G. H. Hu, V. A. Livolsi, and P. K. Gupta, “Fine-needle aspiration of thyroid: an institutional experience,” Thyroid, vol. 8, no. 7, pp. 565–569, 1998.
- I. G. Segovia, H. J. Gallowitsch, E. Kresnik et al., “Descriptive epidemiology of thyroid carcinoma in carinthia, austria: 1984–2001. histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence,” Thyroid, vol. 14, no. 4, pp. 277–286, 2004.
- M. Deandrea, F. Ragazzoni, M. Motta et al., “Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation,” Thyroid, vol. 20, no. 10, pp. 1077–1083, 2010.
- P. Del Rio, R. Minelli, S. Cataldo et al., “Can misdiagnosis in pre-operative FNAC of thyroid nodule influence surgical treatment?” Journal of Endocrinological Investigation, vol. 34, no. 5, pp. 345–348, 2011.
- M. Fukushima, Y. Ito, M. Hirokawa et al., “Excellent prognosis of patients with nonhereditary medullary thyroid carcinoma with ultrasonographic findings of follicular tumor or benign nodule,” World Journal of Surgery, vol. 33, no. 5, pp. 963–968, 2009.
- L. A. Valle and R. T. Kloos, “The prevalence of occult medullary thyroid carcinoma at autopsy,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, pp. 109–113, 2011.
- G. H. Daniels, “Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada,” Thyroid, vol. 21, no. 11, pp. 1199–1207, 2011.
- P. Niccoli, P. Brunet, C. Roubicek et al., “Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis,” European Journal of Endocrinology, vol. 132, no. 1, pp. 75–81, 1995.
- K. Cheung, S. A. Roman, T. S. Wang, H. D. Walker, and J. A. Sosa, “Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 6, pp. 2173–2180, 2008.
- P. Niccoli, N. Wion-Barbot, P. Caron et al., “Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 2, pp. 338–341, 1997.
- J. Vierhapper, W. Raber, C. Bieglmayer, K. Kaserer, A. Weinhäusl, and B. Niederle, “Routine measurement of plasma calcitonin in nodular thyroid diseases,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 5, pp. 1589–1593, 1997.
- R. Elisei, V. Bottici, F. Luchetti et al., “Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 1, pp. 163–168, 2004.
- W. Karges, H. Dralle, F. Raue et al., “Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation,” Experimental and Clinical Endocrinology and Diabetes, vol. 112, no. 1, pp. 52–58, 2004.
- K. Kaserer, C. Scheuba, N. Neuhold et al., “C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin,” American Journal of Surgical Pathology, vol. 22, no. 6, pp. 722–728, 1998.
- C. Scheuba, K. Kaserer, A. Weinhäusl et al., “Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests,” Surgery, vol. 126, no. 6, pp. 1089–1096, 1999.
- M. Iacobone, P. Niccoli-Sire, F. Sebag, C. de Micco, and J. Henry, “Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels,” World Journal of Surgery, vol. 26, no. 8, pp. 886–890, 2002.
- B. Gorman, J. W. Charboneau, E. M. James et al., “Medullary thyroid carcinoma: role of high-resolution US,” Radiology, vol. 162, no. 1, pp. 147–150, 1987.
- S. R. Khini, “Medullary carcinoma,” in Thyroid Cytopathology: An Atlas and Text, S. R. Khini, Ed., pp. 257–287, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2008.